biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > Consequences of a "no" vote: from IR

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Jan 21, 2023 2:59pm

126 Views

Post# 35237600

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Consequences of a "no" vote: from IR

Whatever value that Biodexa might have and develop, it will be shared among 1.2 billion shares, 75% of which are held by people who are here because they put the deal together.

Why do you suppose they did that, poof? Do you think it was an accident that they got that control?

Those prepaid warrants will be valued and disposed of by some action or another and I doubt it will be by exercising them and putting The Placee in a handicapped control position.

A possibility? Some sort of spinout of IP into an entity built from those prepaid warrants, something that will make them go away along with xB3 IP.

That 75% control and those prepaid warrants have meaning.They did it on purpose. LT likely has the power, and Stephen Stamp has stated that he has the power, to finance Biodexa without the placee. It's something you keep pointing out. Is it possible that Stamp would like to see a financing that spreads ownership around rather than being under the control of the placee?

What if Rathjen thinks that xB3 is going elsewhere, that she will be going with it, and that she was brought on board Biodexa for the simple reason of getting this deal done. What if Stamp backs out and decides to keep xB3 and dump Rathjen?

I really don't know, but I do know it's not only wise to be thinking about it, but it's also fun. Always fun to watch capricious people in action.

jd

<< Previous

Bullboard Posts

Next >>

Abcourt Mines launches Flordin property drill campaign